Fast-tracked research leads to phase 1 clinical trials.
Researchers at the University of Alberta are preparing to launch clinical trials of a drug used to cure a deadly disease caused by a coronavirus in cats that they expect will also be effective as a treatment for humans against COVID-19.
In just two months, our results have shown that the drug is effective at inhibiting viral replication in cells with SARS-CoV-2, said Joanne Lemieux, a professor of biochemistry in the Faculty of Medicine & Dentistry.…